Updated hourlyHourly refreshWed, Jul 22, 2026
Press Release Database
Recent press releases, indexed by topic.
AI · Healthcare
(PR-inside.com) EHR fragmentation, payer demands and unproven AI efficiencies are adding hidden labor across clinical workflows CHICAGO, IL / ACCESS Newswire / July 14, 2026 / Black Book Research today releasedThe Work That Didn't Disappear: The Black Book Clinician Reality Index , a nine-month national study finding that healthcare technology is frequently shifting work to clinicians rather than eliminating it. The vendor-agnostic survey of 1,919 clinicians found that 80.7% use at least one workaround every day, while 65.2% lose 30 minutes or more per day or shift to avoidable digital work. Clinicians reported repeatedly re-entering information, reconciling external records, monitoring disconnected queues, checking payer ..
Jul 14 · 12:55·PR-Inside
AI · Healthcare
EHR fragmentation, payer demands and unproven AI efficiencies are adding hidden labor across clinical workflows
Jul 14 · 12:55·Newswire.com
Finance · AI
Access to AMD Developer Cloud credits, AI development tools and technical resources to support next-generation enterprise AI agents Access to AMD Developer Cloud credits, AI development tools and technical resources to support next-generation enterprise AI agents
Jul 14 · 12:55·GlobeNewswire
Healthcare
More than half of new mothers don't fully understand their care plans, while health plan leaders rank member engagement and navigation as a top maternal health priority BALTIMORE, July 14, 2026 /PRNewswire/ -- More communication doesn't necessarily mean better communication for pregnant...
Jul 14 · 12:50·PR Newswire
Healthcare
TORONTO, July 14, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specializing in precision-based cannabinoids, today announced positive results from the Phase II LiBBY (Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol) clinical trial evaluating the Company’s proprietary oral cannabinoid formulation for the treatment of agitation in patients with advanced dementia. The results were presented by the LiBBY team at AAIC in London, United Kingdom on July 14, 2026.
Jul 14 · 12:35·GlobeNewswire
Finance · Healthcare
Sponsors educational summit of leading pediatric AKI health care experts
Jul 14 · 12:34·GlobeNewswire
Healthcare
CALGARY, Alberta, July 14, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. ( TSX-V: VITA.V ; OTCQB: VTLSF ) (" Vitalist "), is pleased to announce that Company CEO Kalvie Legat and CSO Charles Herman will participate in a virtual fireside chat at the Health, Wellness & Longevity Conference presented by Maxim Group on Wednesday, July 22.
Jul 14 · 12:30·GlobeNewswire
AI · Healthcare
(PR-inside.com) First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth MESA, AZ / ACCESS Newswire / July 14, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a major evolution for its popular AI-powered mobile app, Snapshot Recipes, introducing a new freemium model designed to dramatically expand user access while accelerating growth. Download Snapshot Recipes for free now: https://snapshotrecipes.app/get/ Snapshot Recipes empowers users to create instant, personalized recipes by simply snapping a photo of their groceries, open fridge, ingredients, a saved meal image, or even a screenshot from social media. The app instantly delivers chef-inspired recipes with ..
Jul 14 · 12:17·PR-Inside
AI · Healthcare
First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth
Jul 14 · 12:17·Newswire.com
Finance · Healthcare
(PR-inside.com) Funds Advance FDA-Designated Breakthrough Therapy First-in-Class Opioid with Oral Overdose-Protection SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, today announced receipt of a Notice of Award for $5.3 million from the National Institutes on Drug Abuse (NIDA)1 to support the development of its novel MPAR® (Multi-Pill Abuse Resistance) overdose-protection technology, and the lead agent, PF614-MPAR. This marks the third consecutive year of NIDA funding under this award, reflecting sustained institutional confidence in ..
Jul 14 · 12:01·PR-Inside
Finance · Healthcare
(PR-inside.com) 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump Company to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026 SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The ..
Jul 14 · 12:00·PR-Inside
Finance · Healthcare
Funds Advance FDA-Designated Breakthrough Therapy First-in-Class Opioid with Oral Overdose-Protection
Jul 14 · 12:00·Newswire.com